Program Goals

ADA/EASD 2012 Recommendations for Antihyperglycemic Therapy

DPP-4 Inhibitors: Benefits and Risks

DPP-4 Inhibitors: Large-Scale CV Safety Studies

DPP-4 Inhibitor CV Safety Study: SAVOR-TIMI 53

DPP-4 Inhibitor CV Safety Study: EXAMINE

SGLT-2 Inhibitors: Benefits

SGLT-2 Inhibitors: Risks & Adverse Effects

Abbreviations

Abbreviations (cont)

References

References (cont)

References (cont)

References (cont)

References (cont)

References (cont)